Physician profile
Patrick C Toy
NPI 1538374145
$130,438.14
in general payments reported to CMS, 2019-2025
12 companies · $5,062 in 2025
The $5,062 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $47K · 2021: $23K · 2022: $71.29 · 2023: $1,062 · 2024: $4,659 · 2025: $5,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,935 · Food and Beverage: $3,331 · Education: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,935.22 |
| Food and Beverage | $3,330.88 |
| Education | $516.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $73,835.48 | 2020-2025 | Persona, Avenir, Arcos |
| Exactech, INC. | $23,435.49 | 2019-2020 | |
| Medtronic USA, INC. | $12,590.23 | 2019 | |
| Smith+Nephew, INC. | $8,738.40 | 2019-2025 | Renasys Touch |
| Arthrex, INC. | $4,499.11 | 2019-2025 | |
| Encore Medical, Lp | $3,163.82 | 2019 | |
| Gentleman Orthopedic Solutions | $2,065.50 | 2019-2025 | |
| Stryker Corporation | $2,006.65 | 2024 | Mako, Tritanium, Accolade |
| Polynovo North America LLC | $36.28 | 2022 | |
| Heron Therapeutics, INC. | $27.31 | 2025 | Zynrelef |
| Convatec INC. | $24.29 | 2025 | |
| Pacira Therapeutics, INC. | $15.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Toy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.